A detailed history of State Of Wyoming transactions in Macrogenics Inc stock. As of the latest transaction made, State Of Wyoming holds 31,557 shares of MGNX stock, worth $54,278. This represents 0.0% of its overall portfolio holdings.

Number of Shares
31,557
Previous 22,262 41.75%
Holding current value
$54,278
Previous $28,000 35.71%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 19, 2025

BUY
$1.06 - $1.79 $9,852 - $16,638
9,295 Added 41.75%
31,557 $38,000
Q1 2025

May 14, 2025

BUY
$1.26 - $3.49 $28,050 - $77,694
22,262 New
22,262 $28,000
Q2 2022

Aug 15, 2022

SELL
$2.25 - $9.99 $63 - $279
-28 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$8.12 - $16.9 $32 - $67
4 Added 16.67%
28 $0
Q4 2021

Feb 11, 2022

BUY
$15.91 - $21.88 $190 - $262
12 Added 100.0%
24 $0
Q3 2021

Feb 11, 2022

SELL
$19.74 - $28.7 $98 - $143
-5 Reduced 29.41%
12 $0
Q2 2021

Feb 11, 2022

BUY
$20.49 - $35.63 $184 - $320
9 Added 112.5%
17 $0
Q1 2021

Feb 08, 2022

BUY
$18.99 - $33.2 $151 - $265
8 New
8 $0

Others Institutions Holding MGNX

About MACROGENICS INC


  • Ticker MGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 61,458,800
  • Market Cap $106M
  • Description
  • MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...
More about MGNX
Track This Portfolio

Track State Of Wyoming Portfolio

Follow State Of Wyoming and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wyoming with notifications on news.